Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Attracting doctors to low-demand specialties

A role for industry?

- PMLiVE

Signal strength

Communications that connect

- PMLiVE

Novartis gets EU nod for leukaemia drug Rydapt

The FLT3 inhibitor adds to its US approval in AML

- PMLiVE

Alnylam takes off on APOLLO trial results

Provides first late-stage evidence on the biotech's gene-silencing platform

Teva’s Mark Salyer joins Amarin

Takes up newly-created chief commercial officer role

- PMLiVE

FDA approves Medtronic’s tablet-controlled pain device

The Intellis system can be programmed via a Samsung's Galaxy S2

FDA approves Medtronic’s tablet-controlled pain device

The Intellis system can be programmed via a Samsung's Galaxy S2

- PMLiVE

M3 appoints Simon Walker as director of education

In his new role he will lead the company's educational strategy

- PMLiVE

UCB’s antiepileptic drug gains new US indication

FDA approves Briviact as a monotherapy to treat POS

Why AI might be the rep’s best friend

When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...

Anthill Agency

- PMLiVE

With US approval, GSK now needs rapid uptake for COPD triple

Aims to quickly launch the predicted blockbuster to revive its R&D portfolio

Bristol-Myers Squibb (BMS) building

NICE says OK to Opdivo for lung cancer via CDF

Comes after BMS drops the price of its PD-1 inhibitor

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links